Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Monkeypox Cases Spike 20% Weekly Worldwide 17/08/2022 John Heilprin As the first monkeypox case involving a human-to-dog transmission reported, the World Health Organization (WHO) said more than 35,000 recently confirmed cases of monkeypox were accompanied by 12 deaths in 92 nations and territories, including almost 7,500 from last week alone. That made for the second consecutive week with a 20% increase, WHO Director-General Dr […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Monkeypox Variants Get New Names 12/08/2022 Editorial team While the process of renaming monkeypox is still underway, a group of global experts convened by the World Health Organization (WHO) has agreed that the virus’s variants will be renamed with Roman numerals. This follows a meeting convened by the WHO this week to enable virologists and public health experts to reach consensus on new […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> US to Stretch Monkeypox Vaccine Supply Through Intradermal Injections; Experts Warn Plan May Backfire 10/08/2022 Raisa Santos In the aftermath of a national health emergency declaration for Monkeypox, the United States has now decided to split the approved MVA-BN vaccine into five doses in an effort to stretch supply. Some experts, however, have warned that the plan may backfire if health workers are not sufficiently trained in the intradermal skin-based jab technique […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Monkeypox Cases Spike 20% Weekly Worldwide 17/08/2022 John Heilprin As the first monkeypox case involving a human-to-dog transmission reported, the World Health Organization (WHO) said more than 35,000 recently confirmed cases of monkeypox were accompanied by 12 deaths in 92 nations and territories, including almost 7,500 from last week alone. That made for the second consecutive week with a 20% increase, WHO Director-General Dr […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Monkeypox Variants Get New Names 12/08/2022 Editorial team While the process of renaming monkeypox is still underway, a group of global experts convened by the World Health Organization (WHO) has agreed that the virus’s variants will be renamed with Roman numerals. This follows a meeting convened by the WHO this week to enable virologists and public health experts to reach consensus on new […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> US to Stretch Monkeypox Vaccine Supply Through Intradermal Injections; Experts Warn Plan May Backfire 10/08/2022 Raisa Santos In the aftermath of a national health emergency declaration for Monkeypox, the United States has now decided to split the approved MVA-BN vaccine into five doses in an effort to stretch supply. Some experts, however, have warned that the plan may backfire if health workers are not sufficiently trained in the intradermal skin-based jab technique […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Monkeypox Variants Get New Names 12/08/2022 Editorial team While the process of renaming monkeypox is still underway, a group of global experts convened by the World Health Organization (WHO) has agreed that the virus’s variants will be renamed with Roman numerals. This follows a meeting convened by the WHO this week to enable virologists and public health experts to reach consensus on new […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> US to Stretch Monkeypox Vaccine Supply Through Intradermal Injections; Experts Warn Plan May Backfire 10/08/2022 Raisa Santos In the aftermath of a national health emergency declaration for Monkeypox, the United States has now decided to split the approved MVA-BN vaccine into five doses in an effort to stretch supply. Some experts, however, have warned that the plan may backfire if health workers are not sufficiently trained in the intradermal skin-based jab technique […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Monkeypox Variants Get New Names 12/08/2022 Editorial team While the process of renaming monkeypox is still underway, a group of global experts convened by the World Health Organization (WHO) has agreed that the virus’s variants will be renamed with Roman numerals. This follows a meeting convened by the WHO this week to enable virologists and public health experts to reach consensus on new […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> US to Stretch Monkeypox Vaccine Supply Through Intradermal Injections; Experts Warn Plan May Backfire 10/08/2022 Raisa Santos In the aftermath of a national health emergency declaration for Monkeypox, the United States has now decided to split the approved MVA-BN vaccine into five doses in an effort to stretch supply. Some experts, however, have warned that the plan may backfire if health workers are not sufficiently trained in the intradermal skin-based jab technique […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> US to Stretch Monkeypox Vaccine Supply Through Intradermal Injections; Experts Warn Plan May Backfire 10/08/2022 Raisa Santos In the aftermath of a national health emergency declaration for Monkeypox, the United States has now decided to split the approved MVA-BN vaccine into five doses in an effort to stretch supply. Some experts, however, have warned that the plan may backfire if health workers are not sufficiently trained in the intradermal skin-based jab technique […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US to Stretch Monkeypox Vaccine Supply Through Intradermal Injections; Experts Warn Plan May Backfire 10/08/2022 Raisa Santos In the aftermath of a national health emergency declaration for Monkeypox, the United States has now decided to split the approved MVA-BN vaccine into five doses in an effort to stretch supply. Some experts, however, have warned that the plan may backfire if health workers are not sufficiently trained in the intradermal skin-based jab technique […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Posts navigation Older postsNewer posts